• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Diagnostic tools
      • Research team
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Study Type: Review

Bardenheuer Kristina, Dinger Jürgen, Franke Christian, Sicherheit und effektivität von oralen kontrazeptiva bei jugendlichen. Gesundheitswesen. 2010; 72:624.
Shapiro Sid, Dinger Jürgen, Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studies J Fam Plann Reprod Health Care. 2010; 36:33-38. 10.1783/147118910790291037.
Dennerstein L, Lehert P, Bäckström T, Heinemann Klaas, The effect of premenstrual symptoms on activities of daily life. Fertil Steril. 2010; Aug;94(3):1059-64.. 10.1016/j.fertnstert.2009.04.023.
Bäckström T, Heinemann Klaas, Nyberg S, Hammarbäck S, Definition and prevalence of premenstrual syndromes. Gynaecology Forum. 2009; 14(3).
Dinger Jürgen, Oral contraceptives and venous thromboembolism: old questions revisited J Fam Plann Reprod Health Care. 2009; 35:211-213. doi: 10.1783/147118909789587385..
Heinemann Klaas, Rübig A, Strothmann A, Nahum GG, Heinemann Lothar A , Prevalence and opinions of hormone therapy prior to the Women’s Health Initiative: a multinational survey in four continents. J Women’s Health. 2008; 17:1-16.
Heinemann Lothar A , Dinger Jürgen, Klinische Studien – eine Evidenzfalle?. Frauenarzt. 2006; 47:331-35.l.
Heinemann Lothar A , Assmann Anita, Heinemann Klaas, Use of oral contraceptives containing dienogest and risk of venous thromboembolism; an extended summary report. Life and Medical Science Online. 2001; 2.
Feinstein A R, Heinemann Lothar A , Dalessio D, Fox JM, Goldstein J, Haag G, Ladewig D, O'Brien C P , Do caffeine-containing analgesics promote dependence? A review and evaluation Clin Pharmacol Ther. 2001; 68(5):457-67. 10.1067/mcp.2000.110974.
Heinemann Lothar A , Emerging evidence on oral contraceptives and arterial diseases. Proceeding of the symposium on oral contraceptives and cardiovascular disease. Contraception. 2001; 62:29S-36S(Suppl).
Burkman R T, Heinemann Lothar A , Progestins and thrombosis Dialogues in Contraception. 2001; Winter; 7(3):5-7, 8.
Heinemann Lothar A , Aufgebauschte Risikoszenarien (Editorial). Gyno Panorama. 2001; 2:2-3.
  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

sidebar

Search our Publications

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Diagnostic tools
  • Data collection instruments

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2023 ZEG Berlin

Impressum

Website by Laura Yeffeth.